Heartland Advisors Inc. Buys 208,256 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Heartland Advisors Inc. increased its stake in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 55.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 583,545 shares of the business services provider's stock after acquiring an additional 208,256 shares during the period. Stericycle comprises 1.6% of Heartland Advisors Inc.'s holdings, making the stock its 6th largest position. Heartland Advisors Inc. owned approximately 0.63% of Stericycle worth $29,733,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the business. Vanguard Personalized Indexing Management LLC boosted its position in Stericycle by 14.2% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 5,653 shares of the business services provider's stock worth $280,000 after purchasing an additional 705 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Stericycle by 10.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider's stock valued at $97,720,000 after acquiring an additional 192,045 shares in the last quarter. Mesirow Institutional Investment Management Inc. purchased a new position in shares of Stericycle in the fourth quarter valued at approximately $5,381,000. Principal Securities Inc. purchased a new position in shares of Stericycle in the fourth quarter valued at approximately $41,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Stericycle by 2.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,084,459 shares of the business services provider's stock valued at $53,746,000 after acquiring an additional 26,065 shares in the last quarter. Hedge funds and other institutional investors own 98.82% of the company's stock.

Stericycle Trading Up 0.2 %

NASDAQ SRCL traded up $0.09 on Tuesday, reaching $46.56. 269,207 shares of the company were exchanged, compared to its average volume of 463,470. The business's fifty day moving average price is $50.05 and its 200 day moving average price is $48.65. The stock has a market capitalization of $4.32 billion, a P/E ratio of -211.64, a price-to-earnings-growth ratio of 2.53 and a beta of 1.12. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06.

Stericycle (NASDAQ:SRCL - Get Free Report) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping analysts' consensus estimates of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. The firm's revenue for the quarter was down 2.8% compared to the same quarter last year. Analysts forecast that Stericycle, Inc. will post 2.32 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on SRCL shares. Stifel Nicolaus raised their target price on Stericycle from $70.00 to $75.00 and gave the company a "buy" rating in a research report on Thursday, February 29th. Robert W. Baird decreased their target price on Stericycle from $62.00 to $55.00 and set a "neutral" rating on the stock in a research report on Friday, April 26th. Truist Financial decreased their target price on Stericycle from $57.00 to $50.00 and set a "hold" rating on the stock in a research report on Monday, April 29th. StockNews.com downgraded Stericycle from a "buy" rating to a "hold" rating in a research report on Tuesday, April 2nd. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $69.00 price objective on shares of Stericycle in a research note on Thursday, March 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Stericycle currently has a consensus rating of "Hold" and an average price target of $59.40.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.